Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients

Status: Recruiting
Location: See all (9) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

There are \ 85,000 lung cancer patients (LCPs) in the UK; yet only around 8% were recruited into clinical trials in 2021/22. LCPs need opportunities to take part in clinical trials to access new treatments, increasing their quality of life, treatment choices and life expectancy. Discussions with nurses can help patients make better treatment decisions, improving experiences of care. However, research has shown that lung cancer nurses (LCNs) often feel unable to discuss participation in trials with patients due to lack of knowledge, confidence, time and training. This study aims to develop and test a research recruitment tool for LCNs, to support LCPs to enter clinical trials. Objectives include to: * Explore reasons for low uptake of LCPs into clinical trials * Develop a tool for LCNs to talk to patients about clinical trials * Test whether the tool improves the number and quality of discussions nurses have with LCPs about clinical trials The study has four phases: Phase 1: A literature review will identify problems that make clinical trial uptake difficult for LCPs, carers and clinicians Phase 2: Six group discussions with LCNs, patients and carers will explore issues that create potential barriers for patients taking part in clinical trials. The groups will take place online, last approximately one hour and be recorded. Phase 3: Part 1\&2 findings will help us develop a LCN research recruitment tool. The tool will contain information on how nurses obtain information about LC clinical trials, research teams, communication issues, practical issues and how to reach LCPs. Phase 4: The research recruitment tool will be tested in four UK NHS hospitals. A survey will identify any changes in nurses' clinical trials awareness and confidence before and after using the tool. Interviews with LCNs, patients and carers will explore their views on the tool, clinical trials participation and experiences of care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Actively involved in the clinical care pathways of lung cancer patients

• Working at one of the six participating NHS trusts

• Age between 18-65 years of age

• Must have a current diagnosis of lung cancer (any stage) or be the named carer of a person with a lung cancer diagnosis

• Under the care of (or caring for) one of the participating NHS Trusts lung cancer teams

• Aged 18 or over

• Registered nurse with Nursing and Midwifery Council

• Actively involved in the clinical care pathways of lung cancer patients

• Working at one of the six participating NHS trusts

• Age between 18-65 years of age

• Current diagnosis of lung cancer (any stage) or be the named carer of a person with a lung cancer diagnosis

• Aged 18 or over

• Consented to (or carer of someone who has consented to) a clinical trial since start of pilot study

• Receiving care (or carer for someone receiving care) in one of the four NHS sites piloting the research readiness tool

Locations
Other Locations
United Kingdom
Derby and Burton NHS
RECRUITING
Derby
Lanarkshire NHS
RECRUITING
Glasgow
Royal Surrey County Hospital
NOT_YET_RECRUITING
Guildford
St Bartholomews Hospital NHS
NOT_YET_RECRUITING
London
The Royal Marsden NHS
RECRUITING
London
The Christie NHS
RECRUITING
Manchester
Sherwood Forest NHS
RECRUITING
Nottingham
Oxford University Hospitals
RECRUITING
Oxford
Sheffield Teaching Hospitals NHS
RECRUITING
Sheffield
Contact Information
Primary
Catherine L Henshall, PhD
chenshall@brookes.ac.uk
07778 428994
Backup
Iain Williamson, PhD
iwilliamson@dmu.ac.uk
Time Frame
Start Date: 2023-07-01
Estimated Completion Date: 2025-03-30
Participants
Target number of participants: 100
Treatments
Experimental: Intervention tool
A research recruitment tool will be available in paper and online formats and will include information on finding out about LC clinical trials, the role of research teams, embedding research into multidisciplinary team meetings and health needs assessments, communication pathways, signposting LCPs, practical considerations and reaching underrepresented groups. The tool will be used by lung cancer nurses in their daily practice as an aid to support their discussions with lung cancer patients about clinical trial opportunities. They will be asked to complete a survey at three time-points (baseline, three and six months) to measure their self-efficacy, knowledge, confidence and awareness in talking to lung cancer patients about clinical trials.
No_intervention: Control
Lung cancer nurses will undertake usual care. They will be asked to complete a survey at three time-points (baseline, three and six months) to measure their self-efficacy, knowledge, confidence and awareness in talking to lung cancer patients about clinical trials.
Related Therapeutic Areas
Sponsors
Leads: Oxford Brookes University
Collaborators: De Montfort University

This content was sourced from clinicaltrials.gov